https://viromme.com/ https://viromme.com/mdl-001 https://viromme.com/newsroom https://viromme.com/pipeline https://viromme.com/privacy https://viromme.com/contact https://viromme.com/investors https://viromme.com/partner https://viromme.com/science https://viromme.com/impact https://viromme.com/about https://viromme.com/404 https://viromme.com/newsroom/demonstrating-end-to-end-drug-discovery-galileo-unlocks-generative-ai-for-chemistry https://viromme.com/newsroom/model-medicines-icahn-school-of-medicine-at-mount-sinai-and-university-of-california-san-diego-researchers-publish-groundbreaking-preprint-on-mdl-001-a-broad-spectrum-antiviral https://viromme.com/newsroom/mdl001-oral-safe-well-tolerated-broad-spectrum-inhibitor-viral-polymerases https://viromme.com/newsroom/rdrp-thumb-1-a-universal-rna-antiviral-target-and-mdl-001-a-potent-inhibitor